DNTH
Dianthus Therapeutics
$104.49
+$0.62 (+0.6%)Jul 27, 2026
Key metrics
The numbers that frame DNTH today
- Market cap
- $5.71B
- P/E (TTM)
- -32.9
- EV / FCF
- -39.0
- Gross margin
- 100%
- EV / Sales
- 3,806.7
- ROIC
- -38%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $18.08
- 52wk High
- $107.99
Growth
Revenue and earnings trend for DNTH
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DNTH
Is Dianthus Therapeutics a good buy?
Hold. Dianthus Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case. We think Dianthus Therapeutics is selling at a high price.
What is the market capitalization of DNTH?
Dianthus Therapeutics's market capitalization is $5.71B.
What is the P/E ratio for DNTH stock?
Dianthus Therapeutics's current P/E ratio is -32.9.
What is the 52-week high for DNTH stock?
The 52-week high for Dianthus Therapeutics is $107.99. The current close of $104.49 is 3.2% below that high.
What is the 52-week low for DNTH stock?
The 52-week low for Dianthus Therapeutics is $18.08. The current close of $104.49 is 477.9% above that low.
Does DNTH stock pay dividends?
Dianthus Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DNTH?
Dianthus Therapeutics's Debt / Equity ratio is 0.